Wednesday, August 5, 2020

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/33rS6b3

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...